The global market for Peripheral Arterial Interventional Devices was estimated at US$8.7 Billion in 2024 and is projected to reach US$12.3 Billion by 2030, growing at a CAGR of 6.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Peripheral Arterial Interventional Devices market.
Minimally invasive peripheral interventions help restore blood flow, prevent limb amputation, and reduce symptoms such as claudication or ischemic ulcers. As PAD remains underdiagnosed yet increasingly prevalent worldwide, especially in aging populations, the need for reliable interventional solutions is growing in both primary and secondary vascular care settings.
Wire-guided catheters, steerable sheaths, and real-time intravascular imaging tools are enhancing procedural accuracy. Bioabsorbable scaffolds and hybrid stents are under investigation for use in younger patients or those with high restenosis risk. Moreover, integrated procedural kits, including crossing devices and closure systems, are reducing procedural time and simplifying interventions in outpatient settings.
Critical limb ischemia, chronic total occlusions, and complex femoral and below-the-knee lesions are key drivers of device use. As awareness improves among general practitioners and cardiologists, more patients are being referred earlier for diagnostic angiography and interventional management. Device demand is also increasing in high-risk populations with renal impairment, post-surgical graft occlusions, or failed prior stenting.
Expansion of outpatient interventional programs, adoption of same-day discharge protocols, and integration of advanced closure systems are supporting market growth. As patient populations age and chronic vascular diseases become more prevalent, demand for specialized, high-precision peripheral intervention tools continues to increase. Clinical guidelines supporting early PAD intervention and technological progress in next-generation devices are reinforcing long-term growth in this segment.
Segments: Type (Drug-Eluting Stents, Bare Stents, Ordinary Balloon, Drug-Eluting Balloon, Special Balloon); Application (Lower Limbs Application, Renal Artery Application, Carotid Artery Application)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Global Peripheral Arterial Interventional Devices Market - Key Trends & Drivers Summarized
Why Are Peripheral Arterial Interventions Critical for Managing Vascular Diseases?
Peripheral arterial interventional devices are used to diagnose and treat blockages or narrowing in arteries outside the heart, primarily in the limbs. These devices include angioplasty balloons, stents, atherectomy systems, guidewires, embolic protection devices, and drug-coated technologies. They are essential in treating peripheral artery disease (PAD), which affects circulation, mobility, and limb viability, especially in elderly and diabetic patients.Minimally invasive peripheral interventions help restore blood flow, prevent limb amputation, and reduce symptoms such as claudication or ischemic ulcers. As PAD remains underdiagnosed yet increasingly prevalent worldwide, especially in aging populations, the need for reliable interventional solutions is growing in both primary and secondary vascular care settings.
How Are Devices Being Optimized for Complex and Recurrent Arterial Lesions?
Technological innovation in interventional tools has focused on navigating calcified, tortuous, or long lesions with minimal trauma. Drug-coated balloons (DCBs) and drug-eluting stents (DES) are becoming standard in femoropopliteal procedures due to their ability to inhibit restenosis. Atherectomy systems are being refined to debulk plaque effectively without damaging the vessel wall, supporting better long-term outcomes in heavily calcified arteries.Wire-guided catheters, steerable sheaths, and real-time intravascular imaging tools are enhancing procedural accuracy. Bioabsorbable scaffolds and hybrid stents are under investigation for use in younger patients or those with high restenosis risk. Moreover, integrated procedural kits, including crossing devices and closure systems, are reducing procedural time and simplifying interventions in outpatient settings.
Where Is Clinical Use Expanding and Which Conditions Are Fueling Device Adoption?
Interventions for PAD are expanding rapidly across vascular centers, ambulatory surgical centers, and hybrid operating suites. North America and Europe lead in terms of adoption, owing to established PAD screening and reimbursement programs. However, Asia-Pacific is emerging as a high-growth region due to increasing incidence of diabetes, hypertension, and obesity-related vascular conditions.Critical limb ischemia, chronic total occlusions, and complex femoral and below-the-knee lesions are key drivers of device use. As awareness improves among general practitioners and cardiologists, more patients are being referred earlier for diagnostic angiography and interventional management. Device demand is also increasing in high-risk populations with renal impairment, post-surgical graft occlusions, or failed prior stenting.
Growth in the Peripheral Arterial Interventional Devices market is driven by several factors
Growth in the peripheral arterial interventional devices market is driven by factors such as rising global prevalence of PAD, increasing preference for minimally invasive procedures, and continued innovation in drug-coated and atherectomy technologies. Improvements in procedural techniques, stent durability, and imaging guidance are making interventions safer and more effective across a wider range of patients.Expansion of outpatient interventional programs, adoption of same-day discharge protocols, and integration of advanced closure systems are supporting market growth. As patient populations age and chronic vascular diseases become more prevalent, demand for specialized, high-precision peripheral intervention tools continues to increase. Clinical guidelines supporting early PAD intervention and technological progress in next-generation devices are reinforcing long-term growth in this segment.
Scope Of Study:
The report analyzes the Peripheral Arterial Interventional Devices market in terms of units by the following Segments, and Geographic Regions/Countries:Segments: Type (Drug-Eluting Stents, Bare Stents, Ordinary Balloon, Drug-Eluting Balloon, Special Balloon); Application (Lower Limbs Application, Renal Artery Application, Carotid Artery Application)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Drug-Eluting Stents segment, which is expected to reach US$4.0 Billion by 2030 with a CAGR of a 5.1%. The Bare Stents segment is also set to grow at 4.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $2.4 Billion in 2024, and China, forecasted to grow at an impressive 9.2% CAGR to reach $2.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Peripheral Arterial Interventional Devices Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Peripheral Arterial Interventional Devices Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Peripheral Arterial Interventional Devices Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abbott Laboratories, AngioDynamics Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 32 companies featured in this Peripheral Arterial Interventional Devices market report include:
- Abbott Laboratories
- AngioDynamics Inc.
- B. Braun Melsungen AG
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cardinal Health (Cordis)
- Cook Medical
- Gore Medical (W. L. Gore & Associates)
- iVascular S.L.U.
- Kaneka Corporation
- Medtronic plc
- Merit Medical Systems Inc.
- MicroPort Scientific Corporation
- Penumbra Inc.
- Philips (Philips Healthcare)
- Shockwave Medical Inc.
- Surmodics Inc.
- Teleflex Incorporated
- Terumo Corporation
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AngioDynamics Inc.
- B. Braun Melsungen AG
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cardinal Health (Cordis)
- Cook Medical
- Gore Medical (W. L. Gore & Associates)
- iVascular S.L.U.
- Kaneka Corporation
- Medtronic plc
- Merit Medical Systems Inc.
- MicroPort Scientific Corporation
- Penumbra Inc.
- Philips (Philips Healthcare)
- Shockwave Medical Inc.
- Surmodics Inc.
- Teleflex Incorporated
- Terumo Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 275 |
Published | July 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value in 2024 | 8.7 Billion |
Forecasted Market Value by 2030 | 12.3 Billion |
Compound Annual Growth Rate | 6.0% |
Regions Covered | Global |